JNJ-37822681

DB12579InvestigationalSmall molecule

JNJ-37822681 has been used in trials studying the treatment of Schizophrenia.

Chemical structure of JNJ-37822681
Mechanism
Curator reviewed
Formula / weight
C17H17F5N4 · 372.343 g/mol (avg)
Code names
JNJ-37822681

Resolves to

Compound
UNIIGJB2URS7NJCAS935776-74-2ChEMBLCHEMBL3234237PubChem16058752
Structure
InChIKeyUVUYWJWYRLJHEN-UHFFFAOYSA-NSMILESFC1=C(F)C=C(CN2CCC(CC2)NC2=CC=C(N=N2)C(F)(F)F)C=C1
Targets
P14416DRD2

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
26Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with JNJ-37822681, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In